ARTICLE | Clinical News
Velcade bortezomib: Additional Phase I/II data
June 8, 2009 7:00 AM UTC
Additional data from the Phase I/II VERTICAL trial in 15 evaluable patients showed that Velcade plus Treanda bendamustine and Rituxan rituximab produced 8 complete responses and 4 partial responses....